Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析

◆英語タイトル:Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1637
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Intellipharmaceutics International Inc (IPCI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company, which researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosage drugs based on its proprietary technology, Hypermatrix, a multidimensional controlled-release drug delivery platform. Its products and product candidates are used for the treatment of various indications, including neuropathic pain, attention deficit hyperactivity disorder (ADHD), schizophrenia, bipolar disorder, major depressive disorder, hypertension, type 2 diabetes, and chronic angina. It offers a comprehensive range of services, including pre-formulation studies, design, and development through to regulatory approval. Intellipharmaceutics’ is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc Key Recent Developments

Feb 28,2020 Intellipharmaceutics announces fiscal year 2019 results
Feb 05,2020 Intellipharmaceutics announces resignation of chief financial officer
Nov 07,2019 Intellipharmaceutics announces settlement agreement in class action lawsuit, which is subject to court approval
Oct 11,2019 Intellipharmaceutics announces third quarter 2019 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Intellipharmaceutics International Inc – Key Facts
Intellipharmaceutics International Inc – Key Employees
Intellipharmaceutics International Inc – Key Employee Biographies
Intellipharmaceutics International Inc – Major Products and Services
Intellipharmaceutics International Inc – History
Intellipharmaceutics International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Intellipharmaceutics International Inc – Business Description
Intellipharmaceutics International Inc – Corporate Strategy
Intellipharmaceutics International Inc – SWOT Analysis
SWOT Analysis – Overview
Intellipharmaceutics International Inc – Strengths
Intellipharmaceutics International Inc – Weaknesses
Intellipharmaceutics International Inc – Opportunities
Intellipharmaceutics International Inc – Threats
Intellipharmaceutics International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intellipharmaceutics International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 28, 2020: Intellipharmaceutics announces fiscal year 2019 results
Feb 05, 2020: Intellipharmaceutics announces resignation of chief financial officer
Nov 07, 2019: Intellipharmaceutics announces settlement agreement in class action lawsuit, which is subject to court approval
Oct 11, 2019: Intellipharmaceutics announces third quarter 2019 results
Oct 04, 2019: Intellipharmaceutics announces an update in the Purdue Litigation
Jul 10, 2019: Intellipharmaceutics announces second quarter 2019 results
May 29, 2019: Intellipharmaceutics reports director election results
Apr 15, 2019: Intellipharmaceutics announces first quarter 2019 results
Feb 22, 2019: Intellipharmaceutics announces fiscal year 2018 results
Feb 04, 2019: Intellipharmaceutics International names Greg Powell as New Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Intellipharmaceutics International Inc, Key Facts
Intellipharmaceutics International Inc, Key Employees
Intellipharmaceutics International Inc, Key Employee Biographies
Intellipharmaceutics International Inc, Major Products and Services
Intellipharmaceutics International Inc, History
Intellipharmaceutics International Inc, Subsidiaries
Intellipharmaceutics International Inc, Key Competitors
Intellipharmaceutics International Inc, Ratios based on current share price
Intellipharmaceutics International Inc, Annual Ratios
Intellipharmaceutics International Inc, Annual Ratios (Cont...1)
Intellipharmaceutics International Inc, Interim Ratios
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intellipharmaceutics International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Intellipharmaceutics International Inc, Performance Chart (2015 - 2019)
Intellipharmaceutics International Inc, Ratio Charts
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intellipharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Progressive Building Society:企業の戦略・SWOT・財務情報
    Progressive Building Society - Strategy, SWOT and Corporate Finance Report Summary Progressive Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Arista Investors Corp:企業の戦略・SWOT・財務情報
    Arista Investors Corp - Strategy, SWOT and Corporate Finance Report Summary Arista Investors Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sanofi Genzyme:企業のM&A・事業提携・投資動向
    Sanofi Genzyme - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sanofi Genzyme Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • PTC India Ltd (PTC):企業の財務・戦略的SWOT分析
    PTC India Ltd (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Air France-KLM SA:企業のM&A・事業提携・投資動向
    Air France-KLM SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Air France-KLM SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • SEGRO Plc:企業のM&A・事業提携・投資動向
    SEGRO Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEGRO Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Nishimatsu Construction Co Ltd (1820):企業の財務・戦略的SWOT分析
    Nishimatsu Construction Co Ltd (1820) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務情報
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EndoCeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoCeutics Inc (EndoCeutics) is a pharmaceutical company that develops hormone sensitive cancer prevention therapies for women’s health. The company's pipeline product portfolio includes drugs for various indications such as endometriosis; male hypogonadism and antiandrogens, among others. …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Mirati Therapeutics Inc:企業のM&A・事業提携・投資動向
    Mirati Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mirati Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Viacom, Inc.:企業の戦略・SWOT・財務情報
    Viacom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Viacom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kimco Realty Corporation (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corporation (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • DHL International GmbH:企業の戦略的SWOT分析
    DHL International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Yasuhara Chemical Co Ltd (4957):企業の財務・戦略的SWOT分析
    Yasuhara Chemical Co Ltd (4957) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BerGenBio ASA (BGBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary BerGenBio ASA (BerGenBio) is a clinical-stage biopharmaceutical company that develops drugs to treat multiple aggressive cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 is an AXL kinase inhibitor which …
  • Arqvia Group Ltd:企業の戦略・SWOT・財務分析
    Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nichi-Iko Pharmaceutical Co Ltd (4541):企業の財務・戦略的SWOT分析
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆